Abstract:Ghrelin is a novel 28-amino acid peptide with an n-octanoyl ester in the serine 3 that has recently been discovered in rat and human gastrointestinal tract, as an endogenous ligand for growth hormone (GH) secretagogue receptor 1. Ghrelin is produced and stored in granules of the special neuroendocrine cells (A-like cells), located mainly in oxyntic mucosa 2. Ghrelin stimulates GH release and induces a positive energy balance by stimulating food intake and decreasing fat use 3. Ghrelin also has numerous peripheral actions including direct effects on exocrine and endocrine pancreatic functions, carbohydrate metabolism, gastric secretion, stomach motility, and sleep 4. Recently, some authors revealed that administration of ghrelin during reperfusion had protective effects on myocardial ischemia reperfusion injury, including reduced ischemic volume, improvements in coronary flow, and attenuation of lipid peroxidation in a rat model 5. But the exact effect of ghrelin on focal cerebral ischemia reperfusion and the mechanism underlying it are still unknown. Focal cerebral ischemia in adult male Sprague-Dawley rats (weighing 250–280 g) was induced by MCAO (middle cerebral artery occlusion) for 90 min with an intraluminal filament according to the method previously described by Longa 6. Rat ghrelin was administered intraperitoneally (160 μg/kg) 30 min before MCAO and at the beginning of reperfusion. Brain samples were obtained 24 h after MCAO. In this study, we demonstrated that systemic administration of ghrelin significantly reduced infarct volumes from MCAO (data shown in Figure 1A). The protective effect of ghrelin on cell apoptosis and neuronal degeneration after ischemia reperfusion injury was evaluated by TUNEL and Fluoro-Jade B staining, a kind of polyanionic fluorescein derivative that specifically bound to degenerating neurons. In ghrelin-treated group, the number of TUNEL-positive cells and degenerating neurons in the peri-infarct area decreased significantly (Figure 1B,C). Given the fact that ghrelin can pass through the blood–brain barrier 7, these findings suggest that peripherally administered ghrelin enters the brain parenchyma and exerts neuroprotective effects on cerebral ischemia reperfusion. The inhibitive effect of ghrelin on apoptosis was supposed to be related to the activation of PI3K/AKT signaling pathway by the phosphoralation of Akt in an endothelial cell injury 8. Reactive oxygen species (ROS) have been implicated in the pathogenesis of cerebral ischemia reperfusion injury 9. These oxygen-free radicals are directly toxic to neurons and initiate a free radical-mediated cascade causing neuronal damage. To assess the effect of ghrelin on ROS, we evaluated the production of superoxide anion, an important reactive oxygen species (ROS) using DHE (dihydroethidium). In this study, we found superoxide anion production was enhanced after reperfusion, and ghrelin treatment could attenuate it (Figure 2). These might be related to the mechanism that ghrelin could inhibit NADPH oxidase activation and reduce ROS production 10. In summary, we have demonstrated that peripheral administration of ghrelin could protect neurons from ischemic injury caused by MCAO. The protective effects of ghrelin appear to be related with an inhibition of apoptosis and oxidative stress. Our results suggest that ghrelin can function as a neuroprotective agent, and administration of ghrelin may be a novel therapeutic strategy for the treatment of ischemic stroke. This study was supported by National Natural Sciences Foundation of China (30801183), Key Clinical Disciplines Program of Chinese Health Ministry and Grants of Health Bureau of Zhejiang Province (2012).

Ghrelin protects the heart against ischemia/reperfusion injury via inhibition of TLR4/NLRP3 inflammasome pathway

Inhibition of Endoplasm Reticulum Stress by Ghrelin Protects Against Ischemia/reperfusion Injury in Rat Heart.

Protective Effects of Ghrelin on Ischemia/reperfusion Injury in the Isolated Rat Heart.

Protective effects of ghrelin on ischemic/reperfusion injury of isolated hearts in rats

Cardiomyocyte IL-IR2 Protects Heart From Ischemia/Reperfusion Injury by Attenuating NLRP3 Inflammasome Activation and IL-17RA-Mediated Apoptosis

Ghrelin Protects the Myocardium with Hypoxia/reoxygenation Treatment Through Upregulating the Expression of Growth Hormone, Growth Hormone Secretagogue Receptor and Insulin-Like Growth Factor-1, and Promoting the Phosphorylation of Protein Kinase B

Ghrelin Protects Myocardium from Isoproterenol-Induced Injury in Rats

Ghrelin alleviates intestinal ischemia-reperfusion injury by activating the GHSR-1α/Sirt1/FOXO1 pathway

Ghrelin contributes to protection of hepatocellular injury induced by ischaemia/reperfusion.

ER Chaperone GRP78 Protects Heart from Ischemia/Reperfusion Injury Through Akt Activation.

Ghrelin Protects H9c2 Cells from Hydrogen Peroxide-Induced Apoptosis Through NF-κB and Mitochondria-Mediated Signaling

Ghrelin Protects Heart Against ERS-induced Injury and Apoptosis by Activating AMP-activated Protein Kinase

Ghrelin alleviates intestinal ischemia–reperfusion injury by activating the <scp>GHSR</scp>‐1α/Sirt1/<scp>FOXO1</scp> pathway

Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect.

Cardioprotective Effect Of Ghrelin In Cardiopulmonary Bypass Involves A Reduction In Inflammatory Response

Ghrelin protects against ischemia/reperfusion-induced hepatic injury via inhibiting Caspase-11-mediated noncanonical pyroptosis

Acute Effect of Ghrelin on Ischemia/Reperfusion Injury in the Rat Spinal Cord

Ghrelin ameliorates cardiac fibrosis after myocardial infarction by regulating the Nrf2/NADPH/ROS pathway

Ghrelin attenuates intestinal ischemia/reperfusion injury in mice by activating the mTOR signaling pathway

Ghrelin Attenuated Cerebral Ischemia Reperfusion Injury in Rats

Ghrelin inhibited pressure overload-induced cardiac hypertrophy by promoting autophagy via CaMKK/AMPK signaling pathway